期刊文献+

新型莫西沙星衍生物的合成及其抑菌活性

Synthesis and Bacteriostatic Activities of Novel Moxifloxacin Derivatives
下载PDF
导出
摘要 合成了一系列新的含有潜在多活性官能团的新型莫西沙星衍生物,对药物的筛选和制药行业具有重要的应用价值。以莫西沙星为原料,在无催化剂室温反应条件下,与3-甲酸色酮发生Michael加成,然后脱羧开环反应,获得了8个新型莫西沙星衍生物 3a ~ 3h ,产率72%~85%,其结构经 ^(1)H NMR, ^(13)C NMR和 HR-MS (ESI-TOF)表征。该类化合物在莫西沙星骨架上拼接了活性基团水杨酮烯烃,可以为生物活性筛选提供物质基础。采用抑菌圈实验研究了衍生物 3a ~ 3h 的抑菌活性,采用MBC(最低杀菌浓度)和MIC(最低抑菌浓度)实验进一步研究了衍生物 3e 的抑菌活性。结果表明:莫西沙星衍生物 3a ~ 3h 显示了很好的抑菌活性,其中衍生物 3e 的抑菌效果接近阳性对照药莫西沙星,对金黄色葡萄球菌表现出显著的抑制效果。MBC和MIC测试的实验结果 表明 :衍生物 3e 对菌株的抑制效果优于阳性对照药链霉素。 The synthesis of a series of new moxifloxacin derivatives with potential multiple functional groups has important application value for drug screening and pharmaceutical industry.In this paper,the Michael addition and then decarboxylation/ring opening reaction of moxifloxacin with chromone 3-carboxylates was investigated at room temperature without catalyst,to provide a variety of novel moxifloxacin derivatives(3a~3h)in 72%~85%yields.The structures of products 3 were characterized by ^(1)H NMR,^(13)C NMR and HR-MS(ESI-TOF).The antibacterial activity of moxifloxacin derivatives 3a~3h was studied by bacteriostatic ring experiment,and the antibacterial activity of derivative 3e was further studied by MBC(minimum bactericidal concentration)and MIC(minimal inhibitory concentration)experiments.The results showed that these derivatives 3a~3h showed good antibacterial activity,and the antibacterial effect of the derivative 3e was close to that of the positive control drug moxifloxacin,and showed significant antibacterial effect on staphylococcus aureus.MBC and MIC experiments showed that the inhibitory effect of derivative 3e on bacteria was better than that of positive control drug streptomycin.
作者 王芹芹 田方丽 王维娜 刘仁明 刘雄利 陈琳 WANG Qinqin;TIAN Fangli;WANG Weina;LIU Renming;LIU Xiongli;CHEN Lin(National&Local Joint Engineering Research Center for The Exploition of Homology Resources of Medicine and Food,Guizhou University,Guiyang 550025,China)
出处 《合成化学》 CAS 2023年第4期245-251,共7页 Chinese Journal of Synthetic Chemistry
基金 贵州省基础研究项目(黔科合基础-ZK[2022]一般144号)。
关键词 莫西沙星衍生物 3-甲酸色酮 无催化剂 合成 抑菌活性 moxifloxacin derivative chromone 3-carboxylate catalyst-free synthesis bacteriostatic activity
  • 相关文献

参考文献10

二级参考文献61

  • 1沈小庆,王珏,盛炳义,蔡志波.决策分析法在药物经济学研究中的应用[J].中国药学杂志,2004,39(9):709-711. 被引量:22
  • 2王玉和,黎俊华.头孢甲肟与头孢哌酮治疗急性细菌性感染的药物经济学分析[J].中国新药杂志,2006,15(10):830-832. 被引量:5
  • 3社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3032
  • 4格鲁内伯格A 博施P.一种喹啉羧酸盐酸盐的新结晶型体及其制法和药物制剂[P].CN:1160052.1997-09-24.
  • 5乌韦·彼得森 托马斯·申克 克劳斯·葛罗赫 等.含1-二环取代-3-喹诺酮羧酸衍生物的药物组合物制备方法[P].CN:94100328.1995-01-25.
  • 6乌韦·彼得森 托马斯·申克 克劳斯·葛罗赫 等.7.(1-吡咯烷基)-3-喹诺酮-1,5-二氮杂萘酮羧酸衍生物和其制备方法[P].CN:89104574.1990—02—05.
  • 7Lopez H, Vilches V, Scarano S, et al. Multicentre study of the in vitro evaluation of moxifloxacin and other quinolones against community acquired respiratory pathogens [ J ]. Int J Antimicrob Agents, 2001 ; 18 : 379 -382.
  • 8Speciale A, Musumeci R, Blandino G, et al. Minimal inhibitory concentrations and time - kill determination of moxifloxacin against aerobic and anaerobic isolates[J]. Int J Antimicrob Agents,2002; 19:111 - 118.
  • 9Stass H, Kubitza D, Schuhly U. Pharmacokinetics, safety and tolerability of moxifloxacin, a novel 8 - methoxyfluoroquinolone, after repeated oral administration [J]. Clin Pharmacokinet, 2001 ; 40 : 1 - 9.
  • 10George GZ, Ayman MN. Pharmacokinetics and pharmacodynamics , the new fluoroquinolones: focus on respiratory infections [J]. Curr Opinion Pharmacol,2001 ; 1:459 - 463.

共引文献104

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部